RT Journal Article
SR Electronic
T1 Relationship between odor intensity estimates and COVID-19 population prediction in a Swedish sample
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.05.07.20094516
DO 10.1101/2020.05.07.20094516
A1 Iravani, Behzad
A1 Arshamian, Artin
A1 Ravia, Aharon
A1 Mishor, Eva
A1 Snitz, Kobi
A1 Shushan, Sagit
A1 Roth, Yehudah
A1 Perl, Ofer
A1 Honigstein, Danielle
A1 Weissgross, Reut
A1 Karagach, Shiri
A1 Ernst, Gernot
A1 Okamoto, Masako
A1 Mainen, Zachary
A1 Monteleone, Erminio
A1 Dinnella, Caterina
A1 Spinelli, Sara
A1 Mariño-Sánchez, Franklin
A1 Ferdenzi, Camille
A1 Smeets, Monique
A1 Touhara, Kazushige
A1 Bensafi, Moustafa
A1 Hummel, Thomas
A1 Sobel, Noam
A1 Lundström, Johan N.
YR 2020
UL http://medrxiv.org/content/early/2020/05/11/2020.05.07.20094516.abstract
AB In response to the COVID-19 pandemic, countries have implemented various strategies to reduce and slow the spread of the disease in the general population. For countries that have implemented restrictions on its population in a step-wise manner, monitoring of COVID-19 prevalence is of importance to guide decision on when to impose new, or when to abolish old, restrictions. We are here determining whether measures of odor intensity in a large sample can serve as one such measure. Online measures of how intense common household odors are perceived and symptoms of COVID-19 were collected from 2440 Swedes. Average odor intensity ratings were then compared to predicted COVID-19 population prevalence over time in the Swedish population and were found to closely track each other (r=-0.83). Moreover, we found that there was a large difference in rated intensity between individuals with and without COVID-19 symptoms and number of symptoms was related to odor intensity ratings. Finally, we found that individuals progressing from reporting no symptoms to subsequently reporting COVID-19 symptoms demonstrated a large drop in olfactory performance. These data suggest that measures of odor intensity, if obtained in a large and representative sample, can be used as an indicator of COVID-19 disease in the general population. Importantly, this simple measure could easily be implemented in countries without wide-spread access to COVID-19 testing or implemented as a fast early response before widespread testing can be facilitated.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis project was supported by an ERC AdG grant (SocioSmell, 670798), awarded to Noam Sobel, and the writing and analyses by a grant from the Knut and Alice Wallenberg Foundation (KAW 2018.0152), awarded to Johan N. Lundström.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesModel details, raw data, scripts, and figures for the updated model (version 2), that were used as a predictor in this manuscript, can be obtained from an open data deposit: https://github.com/FohmAnalys/SEIR-model-Stockholm https://github.com/FohmAnalys/SEIR-model-Stockholm